The solenopsin analog, compound B (MU-06-SC-608-7), inhibits Akt activation by downregulating its phosphorylation at Thr308 in ras-transformed rat liver epithelial cells WBras1, and human lung cancer cells H2009, while suppressing downstream target proteins along the Akt pathway. This evidence concerns the gene AKT1 and lung carcinoma.